Shiva Biogenetic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-11-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.95 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.70 Cr
as on 16-11-2024
- Revenue -15.63%
(FY 2023)
- Profit -31.85%
(FY 2023)
- Ebitda 13.02%
(FY 2023)
- Net Worth 67.26%
(FY 2023)
- Total Assets -17.11%
(FY 2023)
About Shiva Biogenetic Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹5.95 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parsan Singh, Kunal Bhardwaj, and Kapil Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U24304HP2016PTC008050
- Company No.
041142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shiva Biogenetic Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Bhardwaj  | Director | 21-Jul-2016 | Current |
| Parsan Singh | Director | 13-May-2022 | Current |
| Kapil Bhardwaj | Director | 21-Jul-2016 | Current |
Financial Performance of Shiva Biogenetic Laboratories.
Shiva Biogenetic Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.63% decrease. The company also saw a substantial fall in profitability, with a 31.85% decrease in profit. The company's net worth Soared by an impressive increase of 67.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiva Biogenetic Laboratories?
In 2023, Shiva Biogenetic Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shiva Biogenetic Pharmaceuticals Private LimitedActive 19 years 3 monthsParsan Singh and Kapil Bhardwaj are mutual person
Shiva Lifescience Private LimitedActive 15 years 9 monthsKunal Bhardwaj and Kapil Bhardwaj are mutual person
- Industrialent Chemicals Private LimitedActive 3 years 8 months
Kunal Bhardwaj and Kapil Bhardwaj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Apr 2018 | ₹5.95 Cr | Open |
Axis Bank Limited Creation Date: 28 Mar 2017 | ₹1.70 Cr | Satisfied |
How Many Employees Work at Shiva Biogenetic Laboratories?
Shiva Biogenetic Laboratories has a workforce of 106 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiva Biogenetic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiva Biogenetic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
